Brief: Chimeric Therapeutics Seeks Trading Halt
15/05/2025 03:05
May 15 (Reuters) - Chimeric Therapeutics Ltd CHM.AX: SEEKS TRADING HALT PENDING ANNOUNCEMENT ON NEW DATA FOR ADVENT-AML PHASE 1B CLINICAL TRIAL Further company coverage: CHM.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial